A detailed history of California State Teachers Retirement System transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 2,050,300 shares of GILD stock, worth $189 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,050,300
Previous 2,051,478 0.06%
Holding current value
$189 Million
Previous $141 Million 22.1%
% of portfolio
0.2%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $78,443 - $98,940
-1,178 Reduced 0.06%
2,050,300 $172 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $245,464 - $283,284
-3,887 Reduced 0.19%
2,051,478 $141 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $1.57 Million - $1.91 Million
21,933 Added 1.08%
2,055,365 $151 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $1.97 Million - $2.23 Million
26,852 Added 1.34%
2,033,432 $165 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $5.37 Million - $5.86 Million
-72,615 Reduced 3.49%
2,006,580 $150 Million
Q2 2023

Aug 21, 2023

SELL
$76.01 - $86.7 $9.46 Million - $10.8 Million
-124,493 Reduced 5.65%
2,079,195 $160 Million
Q1 2023

May 09, 2023

SELL
$77.31 - $88.08 $1.59 Million - $1.81 Million
-20,577 Reduced 0.93%
2,203,688 $183 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $2.07 Million - $2.97 Million
33,228 Added 1.52%
2,224,265 $191 Million
Q3 2022

Nov 18, 2022

BUY
$59.54 - $68.01 $2.62 Million - $2.99 Million
43,989 Added 2.05%
2,191,037 $135 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $4,040 - $4,550
70 Added 0.0%
2,147,048 $133 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $7.26 Million - $9.1 Million
-125,421 Reduced 5.52%
2,146,978 $128 Million
Q4 2021

Feb 15, 2022

BUY
$64.88 - $73.64 $5.34 Million - $6.06 Million
82,264 Added 3.76%
2,272,399 $165 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $2.09 Million - $2.26 Million
-30,932 Reduced 1.39%
2,190,135 $153 Million
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $7.51 Million - $8.2 Million
-118,310 Reduced 5.06%
2,221,067 $153 Million
Q1 2021

May 18, 2021

BUY
$60.0 - $68.46 $1.43 Million - $1.64 Million
23,892 Added 1.03%
2,339,377 $151 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $502,598 - $572,687
-8,872 Reduced 0.38%
2,315,485 $135 Million
Q3 2020

Nov 17, 2020

SELL
$62.1 - $78.08 $2.84 Million - $3.58 Million
-45,796 Reduced 1.93%
2,324,357 $147 Million
Q2 2020

Aug 17, 2020

BUY
$72.34 - $84.0 $2.15 Million - $2.5 Million
29,719 Added 1.27%
2,370,153 $182 Million
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $433,211 - $554,881
-6,917 Reduced 0.29%
2,340,434 $175 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $10.4 Million - $11.4 Million
168,621 Added 7.74%
2,347,351 $153 Million
Q3 2019

Nov 15, 2019

BUY
$62.51 - $69.0 $832,820 - $919,287
13,323 Added 0.62%
2,178,730 $138 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $384,460 - $431,127
6,214 Added 0.29%
2,165,407 $146 Million
Q1 2019

May 09, 2019

SELL
$62.53 - $70.05 $1.71 Million - $1.92 Million
-27,343 Reduced 1.25%
2,159,193 $140 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $2.28 Million - $2.97 Million
37,601 Added 1.75%
2,186,536 $137 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $371,653 - $411,488
5,214 Added 0.24%
2,148,935 $166 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $55,926 - $65,236
-862 Reduced 0.04%
2,143,721 $152 Million
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $5.02 Million - $6.12 Million
-68,921 Reduced 3.11%
2,144,583 $162 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $1.22 Million - $1.43 Million
-17,085 Reduced 0.77%
2,213,504 $159 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $161 Million - $191 Million
2,230,589
2,230,589 $181 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.